Review: neoadjuvant chemoradiotherapy and chemotherapy improve survival in operable esophageal cancer
- PMID: 17608384
Review: neoadjuvant chemoradiotherapy and chemotherapy improve survival in operable esophageal cancer
Comment on
-
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.Lancet Oncol. 2007 Mar;8(3):226-34. doi: 10.1016/S1470-2045(07)70039-6. Lancet Oncol. 2007. PMID: 17329193